News from Novocure A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Aug 21, 2014, 13:28 ET

Novocure meldet PMA-Beantragung in Japan zwecks Zulassung des NovoTTF™-100A-Systems zur Behandlung rezidivierter Glioblastome

-- Japanische Gesellschaft für Neuroonkologie fordert zügige Genehmigung durch das japanische Ministerium für Gesundheit, Arbeit und...

Aug 21, 2014, 12:20 ET

Novocure anuncia la entrega de una solicitud de aprobación en Japón para el sistema NovoTTF™-100A

-- Novocure anuncia la entrega de una solicitud de aprobación precomercialización en Japón para el sistema NovoTTF™-100A para...

Aug 21, 2014, 08:00 ET
Aug 21, 2014, 08:00 ET

Novocure Announces the Submission of a Pre-Marketing Approval Application in Japan for the NovoTTF™-100A System to Treat Recurrent Glioblastoma

 Novocure, a commercial stage oncology company, announced today that it has submitted the registration dossier for Pre-Market Approval (PMA) of...

Jul 15, 2014, 08:00 ET

Novocure Announces Commercial Launch of NovoTTF™ Therapy in Europe and Israel

 Novocure, a commercial stage oncology company, announced today that 18 prominent neurosurgeons and neuro-oncologists at medical centers in...

Jun 13, 2014, 08:00 ET

Novocure Announces the Presentation of Subgroup Survival Data for Recurrent Glioblastoma Patients Treated with NovoTTF™ Therapy

 Novocure, a commercial stage oncology company, announced today that subgroup survival data from its U.S. commercial patient registry will be...

May 19, 2014, 10:17 ET

Novocure gibt Veröffentlichung neuer Überlebensdaten für Patienten mit rezidivem Glioblastom bekannt, die einer NovoTTF™-Therapie unterzogen wurden

-- Ein Register von 457 Patienten mit rezidivem Glioblastom zeigt, dass Patienten, die 2012 und 2013 einer kommerziellen NovoTTF-Therapie...

May 19, 2014, 08:29 ET

Novocure anuncia la publicación de nuevos datos sobre la terapia NovoTTF™ para glioblastoma recurrente

- Novocure anuncia la publicación de nuevos datos de supervivencia en pacientes con glioblastoma recurrente tratados con la terapia...

May 19, 2014, 08:00 ET

Novocure Announces the Publication of New Survival Data for Recurrent Glioblastoma Patients Treated with NovoTTF™ Therapy

Novocure, a commercial stage oncology company, announced today that an analysis of the efficacy and safety data from its U.S. patient registry will...

May 19, 2014, 08:00 ET

Novocure annonce la publication de nouvelles données de survie des patients souffrant d'un glioblastome récurrent et suivant un traitement NovoTTF™

-- Un registre de 457 patients souffrant d'un glioblastome récurrent montre que les patients ayant suivi, en 2012 et 2013, un traitement...

May 09, 2014, 10:23 ET

Novocure startet Kampagne zum Monat der Aufklärung über Hirntumoren in diesem Mai zur Unterstützung von Menschen im Kampf gegen das Glioblastom

- Social-Media-Kampagne #TuneIn2GBM soll zur Unterstützung des Kampfs gegen diese tödliche Krebsform auf diese Krankheit aufmerksam...

May 09, 2014, 10:10 ET

Novocure "sintoniza" durante el mes de la concienciación del cáncer cerebral en mayo

- Novocure "sintoniza" durante el mes de la concienciación del cáncer cerebral en mayo para apoyar a las personas que luchan contra el...

May 09, 2014, 07:53 ET
May 08, 2014, 10:00 ET

Novocure "Tunes-In" During Brain Cancer Awareness Month This May to Support People Fighting Glioblastoma

 For the second consecutive year, Novocure is sponsoring its Tune-In to GBM campaign, a public call to action to "Tune-In" to glioblastoma...

Apr 04, 2014, 10:31 ET
Apr 04, 2014, 08:45 ET

Novocure presenta nuevos datos preclínicos sobre la terapia NovoTTF™

- Novocure presenta nuevos datos preclínicos sobre la terapia NovoTTF™ en la reunión anual 2014 de la American Association...

Apr 04, 2014, 08:41 ET

Novocure präsentiert neue präklinische Daten zur NovoTTF™-Therapie auf der Jahrestagung 2014 der American Association for Cancer Research

 Novocure, ein kommerzielles Unternehmen aus dem Bereich der Onkologie, gab heute bekannt, dass im Zuge der vom 5. bis 9. April 2014 in San...

Apr 03, 2014, 10:57 ET

Novocure to Present New Pre-Clinical Data on NovoTTF™ Therapy at the American Association for Cancer Research Annual Meeting 2014

 Novocure, a commercial stage oncology company, announced today that new, pre-clinical data demonstrating the anti-tumor effects of...

Feb 18, 2014, 09:00 ET

Novocure Announces First Commercial License of the NovoTAL™ (Transducer Array Layout) System

  Novocure announced today that Harvard Medical Faculty Physicians at Beth Israel Deaconess Medical Center has licensed the NovoTAL (Transducer...

Jan 24, 2014, 09:00 ET

Novocure Enrolls First Patient in Pilot Clinical Trial of NovoTTF™ Therapy Plus Gemcitabine for First-line Treatment of Advanced Pancreatic Adenocarcinoma

 Novocure announced today that the first patient has enrolled in the EF-20 Study, an open label, pilot clinical trial of NovoTTF Therapy...